FL CARES: Cancer Drug Property Dataset

Pemigatinib US FDA Label

Compound: 11-(2,6-difluoro-3,5-dimethoxyphenyl)-13-ethyl-4-(morpholin-4-ylmethyl)-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-12-one
Description: NA

Brand Name:
Code(s): INCB054828
Approved:
Kinase Class: RY
Inhibitor Type: 1 ½A
Literature (PubMed): 0
Target(s): fibroblast growth factor receptor 1 , fibroblast growth factor receptor 2 , fibroblast growth factor receptor 3
Disease(s): cholangiocarcinoma

International Nonproprietary Name: Pemigatinib [INN] (Source: PubChem)

KEGG Drug ID: D11417 (Source: PubChem)

USFDA Precision ID: UNII-Y6BX7BL23K (Source: PubChem)

United States Adopted Name: Pemigatinib [USAN] (Source: PubChem)

Sources: PubChem (4)